When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like. This episode originally aired on November 8, 2022.
To learn more about how CNN protects listener privacy, visit cnn.com/privacy
Learn more about your ad choices. Visit podcastchoices.com/adchoices
The Role of Race and Ethnicity in Medicine
Why Are Doctors Prescribing Nature?
How Language Lights Up the Brain
The Power of Music
Escaping the Grip of Social Anxiety
It’s Time to Stop Doom Scrolling
11 Months in Space
Your Work is Not Your Life
The Health Benefits of Pets
You're Not Alone
The Mystery of the Teenage Brain
This Is Your Brain on Love
What Memories Are Made Of
In Search of Lost Time
Resetting Expectations
Our Top Takeaways: Worth the Wait
Small Steps. Big Rewards
Our Top Takeaways: Managing Anger
The Science of Grit
(Don’t) Call Me, Maybe
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Up First